Hello and Welcome to Patientsville.com, Your Source for all LIPOVAS information. We are dedicated to provide You with LIPOVAS safety information. Learn about LIPOVAS serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
LIPOVAS Safety Reports
Total LIPOVAS reports: 2.LIPOVAS FDA safety alerts: No.
Reported hospitalizations: 1.
Take LIPOVAS Side Effects Survey or Share Your LIPOVAS Story. Read More Here.
Pharmacist from JAPAN reported LIPOVAS problem on May 30, 2007. Male patient, 66 years of age, was diagnosed with hyperlipidaemia, haemorrhage control, hypertriglyceridaemia and was treated with LIPOVAS. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, coagulopathy, malaise. LIPOVAS dosage: unknown. During the same period patient was treated with WARFARIN POTASSIUM, BEZATOL. Patient was hospitalized. Patient recovered.
LIPOVAS problem was reported by a Physician from JAPAN on Oct 10, 2006. Male patient, 81 years of age, was diagnosed with hyperlipidaemia and was treated with LIPOVAS. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, haemorrhage, musculoskeletal stiffness, tremor. LIPOVAS dosage: unknown. During the same period patient was treated with PERINDOPRIL ERBUMINE, BUFFERIN, ALINAMIN. Patient recovered.